Antimicrobial treatment of multiple sclerosis...Infection. 2006 Dec;34(6):342-4

Detalles Bibliográficos
Publicado en:Infection Vol. 35; no. 5; pp. 383 - 386
Autores principales: Stratton CW, Wheldon DB
Formato: commentary letter Journal Article
Publicado: Springer Nature Oct2007
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105834763&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105834763
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03008126
        NXO
      jtl: Infection
      issn: 03008126
      maglogo: N
    pubinfo:
      dt: Oct2007
      vid: 35
      iid: 5
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        105834763
        2009687793
        10.1007/s15010-007-7036-5
        NLM17882356
        105834763
      ppf: 383
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Antimicrobial treatment of multiple sclerosis...Infection. 2006 Dec;34(6):342-4
      aug:
        au:
          Stratton CW
          Wheldon DB
        affil: The Vanderbilt Clinic 4524-TVC, Vanderbilt University Medical Center, Nashville, TN, USA.
      sug:
        subj:
          Antibiotics Therapeutic Use
          Erythromycin Therapeutic Use
          Gram-Negative Bacteria Drug Effects
          Gram-Negative Bacterial Infections Drug Therapy
          Multiple Sclerosis Complications
      pubtype: Academic Journal
      doctype:
        commentary
        letter
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N